Literature DB >> 29136764

Cardiac apoptosis induced under high glucose condition involves activation of IGF2R signaling in H9c2 cardiomyoblasts and streptozotocin-induced diabetic rat hearts.

Chih-Chung Feng1, Sudhir Pandey2, Ching-Yuang Lin1, Chia-Yao Shen3, Ruey-Lin Chang4, Tung-Ti Chang4, Ray-Jade Chen5, Vijaya Padma Viswanadha6, Yueh-Min Lin7, Chih-Yang Huang8.   

Abstract

The insulin-like growth factor type 2 receptor (IGF2R) overexpression has been implicated in heart disease progression. Unregulated IGF2R signaling triggers cardiac hypertrophy, apoptosis, and cardiomyopathies. The present study investigated the role of IGF2R in cardiomyocyte apoptosis under high glucose (HG) levels and in streptozotocin (STZ) induced diabetic rat hearts. We found that IGF2 and IGF2R protein expression were highly upregulated under high glucose condition in H9c2 cells as well as in STZ induced diabetic rat hearts. Using immunoblotting and TUNEL assay, we found that elevated glucose condition induced IGF2R expression leads to activation of Gαq mediated calcineurin-dependent signaling pathway, which further leads to downstream activation and expression of cardiac hypertrophy related proteins, ANP and BNP. Further, we found that glucose-induced IGF2R expression downregulated survival protein p-Akt, p-Bad (Ser 155) and enhanced the expression of apoptosis-inducing proteins cytochrome c and cleaved Caspase-3. Our results suggested that hyperglycemic condition leads to cellular cardiomyocyte apoptosis both in vitro and in vivo models, via abnormally increased activation of the IGF2R signaling pathway.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Diabetic hyperglycemic; High glucose (HG); IGF2R

Mesh:

Substances:

Year:  2017        PMID: 29136764     DOI: 10.1016/j.biopha.2017.11.020

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Synergistic cardiac pathological hypertrophy induced by high-salt diet in IGF-IIRα cardiac-specific transgenic rats.

Authors:  Ruey-Lin Chang; Srinivasan Nithiyanantham; Chih-Yang Huang; Pei-Ying Pai; Tung-Ti Chang; Lai-Chin Hu; Ray-Jade Chen; V VijayaPadma; Wei-Wen Kuo; Chih-Yang Huang
Journal:  PLoS One       Date:  2019-06-18       Impact factor: 3.240

Review 2.  Role of Insulin-Like Growth Factor Receptor 2 across Muscle Homeostasis: Implications for Treating Muscular Dystrophy.

Authors:  Yvan Torrente; Pamela Bella; Luana Tripodi; Chiara Villa; Andrea Farini
Journal:  Cells       Date:  2020-02-14       Impact factor: 6.600

3.  β-catenin/LEF1/IGF-IIR Signaling Axis Galvanizes the Angiotensin-II- induced Cardiac Hypertrophy.

Authors:  Chin-Hu Lai; Sudhir Pandey; Cecilia Hsuan Day; Tsung-Jung Ho; Ray-Jade Chen; Ruey-Lin Chang; Pei-Ying Pai; V Vijaya Padma; Wei-Wen Kuo; Chih-Yang Huang
Journal:  Int J Mol Sci       Date:  2019-09-02       Impact factor: 5.923

4.  Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1α induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis.

Authors:  Qiaowen Li; Chih-Yang Huang; Shih-Ping Liu; Marthandam Asokan Shibu; Fuu-Jen Tsai; Yuan-Man Hsu; Chang-Hai Tsai; Jing-Gung Chung; Jai-Sing Yang; Chih-Hsin Tang; Shulin Wang
Journal:  Nutr Metab (Lond)       Date:  2020-01-31       Impact factor: 4.169

5.  Gastrodin Exerts Cardioprotective Action via Inhibition of Insulin-Like Growth Factor Type 2/Insulin-Like Growth Factor Type 2 Receptor Expression in Cardiac Hypertrophy.

Authors:  Jun Lu; Xin Ma; Wen-Cong Gao; Xin Zhang; Yuanling Fu; Qian Liu; Lixiang Tian; Xiao-Dan Qin; Weimin Yang; Hong-Yi Zheng; Chang-Bo Zheng
Journal:  ACS Omega       Date:  2021-06-21

Review 6.  Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy.

Authors:  Tarun Pant; Anuradha Dhanasekaran; Juan Fang; Xiaowen Bai; Zeljko J Bosnjak; Mingyu Liang; Zhi-Dong Ge
Journal:  BMC Cardiovasc Disord       Date:  2018-10-20       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.